38552115|t|Unveiling the Role of Novel miRNA PC-5P-12969 in Alleviating Alzheimer's Disease.
38552115|a|Background: The intricate and complex molecular mechanisms that underlie the progression of Alzheimer's disease (AD) have prompted a concerted and vigorous research endeavor aimed at uncovering potential avenues for therapeutic intervention. Objective: This study aims to elucidate the role of miRNA PC-5P-12969 in the pathogenesis of AD. Methods: We assessed the differential expression of miRNA PC-5P-12969 in postmortem AD brains, AD animal and cell models using real-time reverse-transcriptase RT-PCR, we also checked the gene and protein expression of GSK3alpha and APP. Results: Our investigation revealed a notable upregulation of miRNA PC-5P-12969 in postmortem brains of AD patients, in transgenic mouse models of AD, and in mutant APP overexpressing-HT22 cells. Additionally, our findings indicate that overexpression of miRNA PC-5P-12969 exerts a protective effect on cell survival, while concurrently mitigating apoptotic cell death. Further-more, we established a robust and specific interaction between miRNA PC-5P-12969 and GSK3alpha. Our luciferase reporter assays provided confirmation of the binding between miRNA PC-5P-12969 and the 3'-UTR of the GSK3alpha gene. Manipulation of miRNA PC-5P-12969 levels in cellular models of AD yielded noteworthy alterations in the gene and protein expression levels of both GSK3alpha and APP. Remarkably, the manipulation of miRNA PC-5P-12969 levels yielded significant enhancements in mitochondrial respiration and ATP production, concurrently with a reduction in mitochondrial fragmentation, thus unveiling a potential regulatory role of miRNA PC-5P-12969 in these vital cellular processes. Conclusions: In summary, this study sheds light on the crucial role of miRNA PC-5P-12969 and its direct interaction with GSK3alpha in the context of AD.
38552115	34	45	PC-5P-12969	Chemical	-
38552115	61	80	Alzheimer's Disease	Disease	MESH:D000544
38552115	174	193	Alzheimer's disease	Disease	MESH:D000544
38552115	195	197	AD	Disease	MESH:D000544
38552115	417	419	AD	Disease	MESH:D000544
38552115	479	490	PC-5P-12969	Chemical	-
38552115	505	507	AD	Disease	MESH:D000544
38552115	516	518	AD	Disease	MESH:D000544
38552115	639	648	GSK3alpha	Gene	606496
38552115	653	656	APP	Gene	351
38552115	762	764	AD	Disease	MESH:D000544
38552115	765	773	patients	Species	9606
38552115	789	794	mouse	Species	10090
38552115	805	807	AD	Disease	MESH:D000544
38552115	823	826	APP	Gene	351
38552115	842	846	HT22	CellLine	CVCL:0321
38552115	919	930	PC-5P-12969	CellLine	CVCL:5F35
38552115	1105	1116	PC-5P-12969	CellLine	CVCL:5F35
38552115	1121	1130	GSK3alpha	Gene	606496
38552115	1214	1225	PC-5P-12969	CellLine	CVCL:5F35
38552115	1248	1257	GSK3alpha	Gene	606496
38552115	1286	1297	PC-5P-12969	CellLine	CVCL:5F35
38552115	1327	1329	AD	Disease	MESH:D000544
38552115	1411	1420	GSK3alpha	Gene	606496
38552115	1425	1428	APP	Gene	351
38552115	1468	1479	PC-5P-12969	CellLine	CVCL:5F35
38552115	1553	1556	ATP	Chemical	MESH:D000255
38552115	1602	1629	mitochondrial fragmentation	Disease	MESH:D012892
38552115	1683	1694	PC-5P-12969	CellLine	CVCL:5F35
38552115	1807	1818	PC-5P-12969	CellLine	CVCL:5F35
38552115	1851	1860	GSK3alpha	Gene	606496
38552115	1879	1881	AD	Disease	MESH:D000544
38552115	Association	MESH:D000544	606496
38552115	Association	MESH:D000544	351

